NCT04077463 2026-03-17
Chrysalis-2
Janssen Research & Development, LLC
Phase 1 Active not recruiting
Clinical Trials
5 trialsNCT05488314 2026-03-13
METalmark
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT05908734 2026-03-13
PolyDamas
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT06083857 2026-03-11
PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT04538664 2026-02-25
PAPILLON
Janssen Research & Development, LLC
Phase 3 Active not recruiting